Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:e106-e108
Published online before print March 11, 2004, doi: 10.1161/01.STR.0000124458.98123.52
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/5/e106    most recent
01.STR.0000124458.98123.52v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saver, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saver, J. L.
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Neuroprotectors

(Stroke. 2004;35:e106.)
© 2004 American Heart Association, Inc.


Research Report

Prehospital Neuroprotective Therapy for Acute Stroke

Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial

Jeffrey L. Saver, MD; Chelsea Kidwell, MD; Marc Eckstein, MD Sidney Starkman, MD for the FAST-MAG Pilot Trial Investigators

From Stroke Center (J.L.S., C.K., S.S.), Department of Neurology (J.L.S., C.K., S.S.), and Department of Emergency Medicine (S.S.), Geffen School of Medicine of the University of California, Los Angeles; and Department of Emergency Medicine (M.E.), Keck School of Medicine of the University of Southern California and Los Angeles Fire Department.

Correspondence to Dr Jeffrey L. Saver, UCLA Stroke Center, 710 Westwood Plaza, Los Angeles, CA 90095. E-mail jsaver{at}ucla.edu

Background and Purpose— To demonstrate that paramedic initiation of intravenous magnesium sulfate (Mg) in the field in focal stroke patients is feasible, safe, and yields significant time-savings compared with in-hospital initiation of neuroprotective therapy.

Methods— We performed an open-label clinical trial. Inclusion criteria were: (1) likely stroke as identified by the Los Angeles Prehospital Stroke Screen; (2) age 45 to 95; and (3) treatment initiation within 12 hours of symptom onset. Paramedics initiated 4 g Mg loading dose in the field, followed by 16 g over 24 hours in hospital.

Results— Twenty patients were enrolled, with mean age 74 (range 44 to 92), and 50% were male. Final diagnosis was acute cerebrovascular disease in all (ischemic 80%, hemorrhagic 20%). Study agent infusion began a median of 100 minutes after symptom onset (range 24 to 703), and 70% received study agent within 2 hours of onset. The interval from paramedic arrival on scene to study agent start was: field-initiated, 26 minutes (range 15 to 64) versus in-hospital initiated (historic controls), 139 minutes (range 66 to 300; P<0.0001). Paramedics rated patient status on hospital arrival as improved 20%, worsened 5%, and unchanged 75%. Median NIHSS on hospital arrival was 11 in all patients and 16 in patients unchanged since field treatment start. Good functional outcome at 3 months (Rankin <= 2) occurred in 60%. No serious adverse events were associated with field therapy initiation.

Conclusions— Field initiation of Mg sulfate in acute stroke patients is feasible and safe. Prehospital trial conduct substantially reduces on-scene to needle time and permits hyperacute delivery of neuroprotective therapy.


Key Words: stroke • neuroprotection • emergency medical services • clinical trials




This article has been cited by other articles:


Home page
Journal of NeuroInterventional SurgeryHome page
R Novakovic, G Toth, and P D Purdy
Review of current and emerging therapies in acute ischemic stroke
JNIS, July 1, 2009; 1(1): 13 - 26.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. P. Meloni, K. Campbell, H. Zhu, and N. W. Knuckey
In Search of Clinical Neuroprotection After Brain Ischemia: The Case for Mild Hypothermia (35{degrees}C) and Magnesium
Stroke, June 1, 2009; 40(6): 2236 - 2240.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. C. Leira, A. Ahmed, D. L. Lamb, H. M. Olalde, R. C. Callison, J. C. Torner, H. P. Adams Jr, and for the AIRDOC study Investigators
Extending Acute Trials to Remote Populations: A Pilot Study During Interhospital Helicopter Transfer
Stroke, March 1, 2009; 40(3): 895 - 901.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. D. Ginsberg
Current Status of Neuroprotection for Cerebral Ischemia: Synoptic Overview
Stroke, March 1, 2009; 40(3_suppl_1): S111 - S114.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Alberts, R. A. Felberg, L. R. Guterman, S. R. Levine, and for Writing Group 4
Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art
Circulation, December 16, 2008; 118(25): 2845 - 2851.
[Full Text] [PDF]


Home page
Arch NeurolHome page
E. C. Leira, D. C. Hess, J. C. Torner, and H. P. Adams Jr
Rural-Urban Differences in Acute Stroke Management Practices: A Modifiable Disparity
Arch Neurol, July 1, 2008; 65(7): 887 - 891.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. A. Donnan and S. M. Davis
Neuroprotection: Still Achievable in Humans
Stroke, February 1, 2008; 39(2): 525 - 525.
[Full Text] [PDF]


Home page
StrokeHome page
J. E. Acker III, A. M. Pancioli, T. J. Crocco, M. K. Eckstein, E. C. Jauch, H. Larrabee, N. M. Meltzer, W. C. Mergendahl, J. W. Munn, S. M. Prentiss, et al.
Implementation Strategies for Emergency Medical Services Within Stroke Systems of Care: A Policy Statement From the American Heart Association/ American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council
Stroke, November 1, 2007; 38(11): 3097 - 3115.
[Full Text] [PDF]


Home page
StrokeHome page
P. D. Lyden, A. Shuaib, K. R. Lees, A. Davalos, S. M. Davis, H.-C. Diener, J. C. Grotta, T. J. Ashwood, H.-G. Hardemark, H. H. Svensson, et al.
Safety and Tolerability of NXY-059 for Acute Intracerebral Hemorrhage: The CHANT Trial
Stroke, August 1, 2007; 38(8): 2262 - 2269.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. A. Sattin, S. E. Olson, L. Liu, R. Raman, and P. D. Lyden
An Expedited Code Stroke Protocol Is Feasible and Safe
Stroke, December 1, 2006; 37(12): 2935 - 2939.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
D. H. Rhoney and D. Parker Jr
Considerations in Fluids and Electrolytes After Traumatic Brain Injury
Nutr Clin Pract, October 1, 2006; 21(5): 462 - 478.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Scott
For Rich and Poor, the Message Is Still "Dial 9-1-1": But Is It Getting Through?
Stroke, June 1, 2006; 37(6): 1354 - 1355.
[Full Text] [PDF]


Home page
StrokeHome page
C. A. Molina and J. L. Saver
Extending Reperfusion Therapy for Acute Ischemic Stroke: Emerging Pharmacological, Mechanical, and Imaging Strategies
Stroke, October 1, 2005; 36(10): 2311 - 2320.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Adams, R. Adams, G. Del Zoppo, and L. B. Goldstein
Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association
Stroke, April 1, 2005; 36(4): 916 - 923.
[Full Text] [PDF]


Home page
StrokeHome page
D. Hanley and W. Hacke
Critical Care and Emergency Medicine Neurology in Stroke
Stroke, February 1, 2005; 36(2): 205 - 207.
[Full Text] [PDF]


Home page
StrokeHome page
V. K. Gupta, J. L. Saver, C. Kidwell, M. Eckstein, S. Starkman, and for the FAST-MAG Pilot Trial Investigators
Intravenous Magnesium for Neuroprotection in Acute Stroke: Clinical Hope Versus Basic Neuropharmacology * Intravenous Magnesium for Neuroprotection in Acute Stroke: Neuropharmacology Supports Clinical Hope: Response:
Stroke, December 1, 2004; 35(12): 2758 - 2759.
[Full Text] [PDF]


Home page
StrokeHome page
R. M. Zweifler, M. E. Voorhees, M. A. Mahmood, and M. Parnell
Magnesium Sulfate Increases the Rate of Hypothermia Via Surface Cooling and Improves Comfort
Stroke, October 1, 2004; 35(10): 2331 - 2334.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. A. Zivin
SLOW-MAG
Stroke, July 1, 2004; 35(7): 1776 - 1777.
[Full Text] [PDF]